Sarah A. Frech

1.3k total citations
10 papers, 815 citations indexed

About

Sarah A. Frech is a scholar working on Epidemiology, Infectious Diseases and Immunology. According to data from OpenAlex, Sarah A. Frech has authored 10 papers receiving a total of 815 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Epidemiology, 4 papers in Infectious Diseases and 4 papers in Immunology. Recurrent topics in Sarah A. Frech's work include Immunotherapy and Immune Responses (3 papers), Dermatology and Skin Diseases (3 papers) and Transgenic Plants and Applications (3 papers). Sarah A. Frech is often cited by papers focused on Immunotherapy and Immune Responses (3 papers), Dermatology and Skin Diseases (3 papers) and Transgenic Plants and Applications (3 papers). Sarah A. Frech collaborates with scholars based in United States, United Kingdom and New Zealand. Sarah A. Frech's co-authors include Gregory M. Glenn, Richard T. Kenney, Larry R. Muenz, Larry Ellingsworth, David C. Flyer, Robin McKenzie, A. Louis Bourgeois, Jianmei Yu, J. Paul Zoeteweij and Scott A. Hammond and has published in prestigious journals such as New England Journal of Medicine, The Journal of Infectious Diseases and American Journal of Obstetrics and Gynecology.

In The Last Decade

Sarah A. Frech

10 papers receiving 746 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sarah A. Frech United States 9 371 253 235 195 174 10 815
Jianmei Yu United States 12 304 0.8× 100 0.4× 141 0.6× 116 0.6× 103 0.6× 13 557
Steve Rockman Australia 14 293 0.8× 441 1.7× 129 0.5× 240 1.2× 65 0.4× 26 777
Russell Vassell United States 20 602 1.6× 441 1.7× 108 0.5× 545 2.8× 79 0.5× 41 1.4k
P.H. Lambert Switzerland 12 213 0.6× 102 0.4× 65 0.3× 178 0.9× 22 0.1× 27 718
Christian Van Hoecke United States 11 245 0.7× 292 1.2× 51 0.2× 224 1.1× 34 0.2× 12 681
Toshiya Koga United States 12 477 1.3× 145 0.6× 24 0.1× 121 0.6× 15 0.1× 18 825
Miroslav Novák United States 16 318 0.9× 308 1.2× 71 0.3× 140 0.7× 7 0.0× 31 780
Alexandra C. I. Depelsenaire Australia 12 150 0.4× 60 0.2× 201 0.9× 299 1.5× 116 0.7× 14 657
Tomoko Kiyohara Japan 17 68 0.2× 448 1.8× 47 0.2× 233 1.2× 25 0.1× 35 837
Ross W. Ward Ireland 6 241 0.6× 136 0.5× 37 0.2× 222 1.1× 10 0.1× 12 527

Countries citing papers authored by Sarah A. Frech

Since Specialization
Citations

This map shows the geographic impact of Sarah A. Frech's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah A. Frech with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah A. Frech more than expected).

Fields of papers citing papers by Sarah A. Frech

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah A. Frech. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah A. Frech. The network helps show where Sarah A. Frech may publish in the future.

Co-authorship network of co-authors of Sarah A. Frech

This figure shows the co-authorship network connecting the top 25 collaborators of Sarah A. Frech. A scholar is included among the top collaborators of Sarah A. Frech based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah A. Frech. Sarah A. Frech is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Shakib, Julie H., Michael W. Varner, Adrian Trenholme, et al.. (2019). Immunoglobulin A, immunoglobulin G, and neutralizing antibodies to respiratory syncytial virus increase in human milk following immunization with an RSV F protein vaccine. American Journal of Obstetrics and Gynecology. 221(6). 669–670. 2 indexed citations
3.
Ellingsworth, Larry, et al.. (2008). Controlled, single-step, stratum corneum disruption as a pretreatment for immunization via a patch. Vaccine. 26(22). 2782–2787. 44 indexed citations
4.
McKenzie, Robin, A. Louis Bourgeois, Sarah A. Frech, et al.. (2007). Transcutaneous immunization with the heat-labile toxin (LT) of enterotoxigenic Escherichia coli (ETEC): Protective efficacy in a double-blind, placebo-controlled challenge study. Vaccine. 25(18). 3684–3691. 93 indexed citations
5.
Glenn, Gregory M., David C. Flyer, A. Louis Bourgeois, et al.. (2007). Safety and Immunogenicity of an Enterotoxigenic Escherichia coli Vaccine Patch Containing Heat-Labile Toxin: Use of Skin Pretreatment To Disrupt the Stratum Corneum. Infection and Immunity. 75(5). 2163–2170. 52 indexed citations
6.
Glenn, Gregory M., David C. Flyer, Larry Ellingsworth, et al.. (2007). Transcutaneous immunization with heat-labile enterotoxin: development of a needle-free vaccine patch. Expert Review of Vaccines. 6(5). 809–819. 45 indexed citations
7.
Kenney, Richard T., Jianmei Yu, Mimi Guebre‐Xabier, et al.. (2004). Induction of Protective Immunity against Lethal Anthrax Challenge with a Patch. The Journal of Infectious Diseases. 190(4). 774–782. 57 indexed citations
8.
Frech, Sarah A., Richard T. Kenney, Hedvika Lazar, et al.. (2004). Improved immune responses to influenza vaccination in the elderly using an immunostimulant patch. Vaccine. 23(7). 946–950. 68 indexed citations
9.
Kenney, Richard T., et al.. (2004). Dose Sparing with Intradermal Injection of Influenza Vaccine. New England Journal of Medicine. 351(22). 2295–2301. 336 indexed citations
10.
Glenn, Gregory M., Richard T. Kenney, Larry Ellingsworth, et al.. (2003). Transcutaneous immunization and immunostimulant strategies: capitalizing on the immunocompetence of the skin. Expert Review of Vaccines. 2(2). 253–267. 101 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026